These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 28497567)

  • 1. Determination of disease phenotypes and pathogenic variants from exome sequence data in the CAGI 4 gene panel challenge.
    Kundu K; Pal LR; Yin Y; Moult J
    Hum Mutat; 2017 Sep; 38(9):1201-1216. PubMed ID: 28497567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A community-based resource for automatic exome variant-calling and annotation in Mendelian disorders.
    Mutarelli M; Marwah V; Rispoli R; Carrella D; Dharmalingam G; Oliva G; di Bernardo D
    BMC Genomics; 2014; 15 Suppl 3(Suppl 3):S5. PubMed ID: 25078076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pitfalls of clinical exome and gene panel testing: alternative transcripts.
    Bodian DL; Kothiyal P; Hauser NS
    Genet Med; 2019 May; 21(5):1240-1245. PubMed ID: 30293991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosing rare diseases after the exome.
    Frésard L; Montgomery SB
    Cold Spring Harb Mol Case Stud; 2018 Dec; 4(6):. PubMed ID: 30559314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Next-generation sequencing using a pre-designed gene panel for the molecular diagnosis of congenital disorders in pediatric patients.
    Lim EC; Brett M; Lai AH; Lee SP; Tan ES; Jamuar SS; Ng IS; Tan EC
    Hum Genomics; 2015 Dec; 9():33. PubMed ID: 26666243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ensemble variant interpretation methods to predict enzyme activity and assign pathogenicity in the CAGI4 NAGLU (Human N-acetyl-glucosaminidase) and UBE2I (Human SUMO-ligase) challenges.
    Yin Y; Kundu K; Pal LR; Moult J
    Hum Mutat; 2017 Sep; 38(9):1109-1122. PubMed ID: 28544272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prioritization of oligogenic variant combinations in whole exomes.
    Gravel B; Renaux A; Papadimitriou S; Smits G; Nowé A; Lenaerts T
    Bioinformatics; 2024 Mar; 40(4):. PubMed ID: 38603604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CAGI4 Crohn's exome challenge: Marker SNP versus exome variant models for assigning risk of Crohn disease.
    Pal LR; Kundu K; Yin Y; Moult J
    Hum Mutat; 2017 Sep; 38(9):1225-1234. PubMed ID: 28512778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of intellectual disability and autism comorbidity through gene panel sequencing.
    Aspromonte MC; Bellini M; Gasparini A; Carraro M; Bettella E; Polli R; Cesca F; Bigoni S; Boni S; Carlet O; Negrin S; Mammi I; Milani D; Peron A; Sartori S; Toldo I; Soli F; Turolla L; Stanzial F; Benedicenti F; Marino-Buslje C; Tosatto SCE; Murgia A; Leonardi E
    Hum Mutat; 2019 Sep; 40(9):1346-1363. PubMed ID: 31209962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of a Targeted Gene Panel for Identification of Genes Associated With Movement Disorders.
    Montaut S; Tranchant C; Drouot N; Rudolf G; Guissart C; Tarabeux J; Stemmelen T; Velt A; Fourrage C; Nitschké P; Gerard B; Mandel JL; Koenig M; Chelly J; Anheim M;
    JAMA Neurol; 2018 Oct; 75(10):1234-1245. PubMed ID: 29913018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variant recurrence in neurodevelopmental disorders: the use of publicly available genomic data identifies clinically relevant pathogenic missense variants.
    Lecoquierre F; Duffourd Y; Vitobello A; Bruel AL; Urteaga B; Coubes C; Garret P; Nambot S; Chevarin M; Jouan T; Moutton S; ; Tran-Mau-Them F; Philippe C; Sorlin A; Faivre L; Thauvin-Robinet C
    Genet Med; 2019 Nov; 21(11):2504-2511. PubMed ID: 31036916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CAGI4 SickKids clinical genomes challenge: A pipeline for identifying pathogenic variants.
    Pal LR; Kundu K; Yin Y; Moult J
    Hum Mutat; 2017 Sep; 38(9):1169-1181. PubMed ID: 28512736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Working toward precision medicine: Predicting phenotypes from exomes in the Critical Assessment of Genome Interpretation (CAGI) challenges.
    Daneshjou R; Wang Y; Bromberg Y; Bovo S; Martelli PL; Babbi G; Lena PD; Casadio R; Edwards M; Gifford D; Jones DT; Sundaram L; Bhat RR; Li X; Pal LR; Kundu K; Yin Y; Moult J; Jiang Y; Pejaver V; Pagel KA; Li B; Mooney SD; Radivojac P; Shah S; Carraro M; Gasparini A; Leonardi E; Giollo M; Ferrari C; Tosatto SCE; Bachar E; Azaria JR; Ofran Y; Unger R; Niroula A; Vihinen M; Chang B; Wang MH; Franke A; Petersen BS; Pirooznia M; Zandi P; McCombie R; Potash JB; Altman RB; Klein TE; Hoskins RA; Repo S; Brenner SE; Morgan AA
    Hum Mutat; 2017 Sep; 38(9):1182-1192. PubMed ID: 28634997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Exome-Targeted Capture Sequencing to Detect Mutations in Known Cerebellar Ataxia Genes.
    Coutelier M; Hammer MB; Stevanin G; Monin ML; Davoine CS; Mochel F; Labauge P; Ewenczyk C; Ding J; Gibbs JR; Hannequin D; Melki J; Toutain A; Laugel V; Forlani S; Charles P; Broussolle E; Thobois S; Afenjar A; Anheim M; Calvas P; Castelnovo G; de Broucker T; Vidailhet M; Moulignier A; Ghnassia RT; Tallaksen C; Mignot C; Goizet C; Le Ber I; Ollagnon-Roman E; Pouget J; Brice A; Singleton A; Durr A;
    JAMA Neurol; 2018 May; 75(5):591-599. PubMed ID: 29482223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective Evaluation of the Utility of Whole Exome Sequencing in Dilated Cardiomyopathy.
    Ramchand J; Wallis M; Macciocca I; Lynch E; Farouque O; Martyn M; Phelan D; Chong B; Lockwood S; Weintraub R; Thompson T; Trainer A; Zentner D; Vohra J; Chetrit M; Hare DL; James P
    J Am Heart Assoc; 2020 Jan; 9(2):e013346. PubMed ID: 31931689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted exome sequencing reveals distinct pathogenic variants in Iranians with colorectal cancer.
    Ashktorab H; Mokarram P; Azimi H; Olumi H; Varma S; Nickerson ML; Brim H
    Oncotarget; 2017 Jan; 8(5):7852-7866. PubMed ID: 28002797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. mirVAFC: A Web Server for Prioritizations of Pathogenic Sequence Variants from Exome Sequencing Data via Classifications.
    Li Z; Liu Z; Jiang Y; Chen D; Ran X; Sun ZS; Wu J
    Hum Mutat; 2017 Jan; 38(1):25-33. PubMed ID: 27676360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical next generation sequencing in developmental and epileptic encephalopathies: Diagnostic relevance of data re-analysis and variants re-interpretation.
    Salinas V; Martínez N; Maturo JP; Rodriguez-Quiroga SA; Zavala L; Medina N; Amartino H; Sfaello I; Agosta G; Serafín EM; Morón DG; Kauffman MA; Vega P
    Eur J Med Genet; 2021 Dec; 64(12):104363. PubMed ID: 34673242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic diagnosis of infantile-onset epilepsy in the clinic: Application of whole-exome sequencing following epilepsy gene panel testing.
    Kim SY; Jang SS; Kim H; Hwang H; Choi JE; Chae JH; Kim KJ; Lim BC
    Clin Genet; 2021 Mar; 99(3):418-424. PubMed ID: 33349918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translational Diagnostics: An In-House Pipeline to Validate Genetic Variants in Children with Undiagnosed and Rare Diseases.
    Pijuan J; Rodríguez-Sanz M; Natera-de Benito D; Ortez C; Altimir A; Osuna-López M; Roura M; Ugalde M; Van de Vondel L; Reina-Castillón J; Fons C; Benítez R; Nascimento A; Hoenicka J; Palau F
    J Mol Diagn; 2021 Jan; 23(1):71-90. PubMed ID: 33223419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.